ReviewMolecular pathology : MP2001
Guillain Barré syndrome.
Review in Molecular pathology : MP, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 125 citations in OpenAlex.
- Cytomegalovirus-Associated Parainfectious Miller Fisher Syndrome Without Anti-GQ1b Antibodies: A Case Report.The Neurohospitalist · 2026Article
- Neurolymphomatosis mimicking a Guillain-Barré syndrome triggered by COVID-19 vaccination.Neuropathology : official journal of the Japanese Society of Neuropathology · 2025Article
- A rare kind of Guillain-Barre syndrome triggered by acute hepatitis A infection in a pediatric patient: a case report and review of literature.Journal of neurovirology · 2024Review
- Early Neurophysiological Abnormalities in Suspected Acute Canine Polyradiculoneuropathy.Veterinary sciences · 2024Article
- Article
- SARS-CoV-2 triggering autoimmune diseases.Cytokine · 2022Review
- Is there a difference between GBS triggered by COVID-19 and those of other origins?The Egyptian journal of neurology, psychiatry and neurosurgery · 2022Article
- Guillain-Barré Syndrome in a Patient with Sickle Cell Anemia.HCA healthcare journal of medicine · 2021Article
- Epidemiology of Guillain-Barré Syndrome in Iranian Children Aged 0-15 Years (2008-2013).Iranian journal of child neurology · 2021Article
- Article
- Guillain-Barré syndrome in a man presenting with upper extremity monoplegia.Clinical case reports · 2020Article
- Guillain-Barré Syndrome Secondary to West Nile Virus in New York City.Case reports in infectious diseases · 2020Article
- Faster Recovery of Internal Ophthalmoplegia than External Ophthalmoplegia in a Miller Fisher Variant of Guillain-Barre Syndrome.Case reports in ophthalmological medicine · 2020Article
- Human leukocyte antigen-DQB1 polymorphisms and haplotype patterns in Guillain-Barré syndrome.Annals of clinical and translational neurology · 2019Article
- Pulse-steroid therapy in a 37-year-old man with acute motor and sensory axonal neuropathy: A case report.Clinical case reports · 2019Article
- A Co-Occurrence of Serologically Proven Myasthenia Gravis and Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome.Case reports in neurological medicine · 2019Article
- Natural Diterpenoid Oridonin Ameliorates Experimental Autoimmune Neuritis by Promoting Anti-inflammatory Macrophages Through Blocking Notch Pathway.Frontiers in neuroscience · 2019Article
- Intentions to use a novel Zika vaccine: the effects of misbeliefs about the MMR vaccine and perceptions about Zika.Journal of public health (Oxford, England) · 2018Article
- VEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritis.Brain, behavior, and immunity · 2018Article
- Guillain-Barré syndrome in a Child with Ongoing Viral Hepatitis A.Iranian journal of child neurology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guillain Barré syndrome is one of the best examples of a post infectious immune disease and offers insights into the mechanism of tissue damage in other more common autoimmune diseases. Controlled epidemiological studies have linked it to infection with Campylobacter jejuni in addition to other viruses including cytomegalovirus and Epstein Barr virus. The syndrome includes several pathological subtypes, of which the most common is a multifocal demyelinating disorder of the peripheral nerves in close association with macrophages. Evidence from histological examination of peripheral nerve biopsy and postmortem samples suggests that both cell mediated and humoral mechanisms are involved in the pathogenesis. Immunological studies suggest that at least one third of patients have antibodies against nerve gangliosides, which in some cases also react with constituents of the liposaccharide of C jejuni. In the Miller Fisher variant of the disease, these antiganglioside antibodies have been shown to produce neuromuscular block, and may in part explain the clinical signs of that disorder. Treatment with both intravenous immunoglobulin and plasma exchange reduces the time taken for recovery to occur, although mortality remains around 8%, with about 20% of patients remaining disabled.
Indexed as
Identifiers
11724912PMC1187127W1908861562What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.